0001104659-23-091529 Sample Contracts

Contract
Zynerba Pharmaceuticals, Inc. • August 14th, 2023 • Pharmaceutical preparations
Sample 1
AutoNDA by SimpleDocs
Contract
Zynerba Pharmaceuticals, Inc. • August 14th, 2023 • Pharmaceutical preparations
Sample 1
Contract
Zynerba Pharmaceuticals, Inc. • August 14th, 2023 • Pharmaceutical preparations
Sample 1
Contract
Zynerba Pharmaceuticals, Inc. • August 14th, 2023 • Pharmaceutical preparations
Sample 1
Contract
Zynerba Pharmaceuticals, Inc. • August 14th, 2023 • Pharmaceutical preparations
Sample 1
Good day,
Zynerba Pharmaceuticals, Inc. • August 14th, 2023 • Pharmaceutical preparations

As announced this morning in a joint press release (attached), Harmony Biosciences Holdings, Inc. (“Harmony”), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases, has entered into a definitive agreement to acquire Zynerba Pharmaceuticals, Inc. (“Zynerba”). The acquisition is intended to support Harmony’s goal of building a diversified portfolio of innovative assets that treat rare neuropsychiatric disorders. The transaction is expected to close by the fourth quarter of 2023, subject to customary closing conditions.

Sample 1
Contract
Zynerba Pharmaceuticals, Inc. • August 14th, 2023 • Pharmaceutical preparations
Sample 1
Contract
Zynerba Pharmaceuticals, Inc. • August 14th, 2023 • Pharmaceutical preparations
Sample 1
Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!